Showing 141 - 160 results of 76,255 for search '(( significant decrease based ) OR ( significant ((ns decrease) OR (a decrease)) ))', query time: 0.40s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147

    HFD decreases ITM and alters metabolic homeostasis. by Tong Yue (6033305)

    Published 2025
    “…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”
  8. 148
  9. 149
  10. 150

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  11. 151
  12. 152
  13. 153

    Depletion of ERp29 decreases cellular Proinsulin. by Jeffrey Viviano (8871581)

    Published 2020
    “…(D, E) Transiently transfected Min-6 cells were lysed and analyzed by ELISA. Proinsulin levels decreased when transfected with ERp29-targeting siRNA as compared to controls (D, p = 0.0309), but Insulin content did not significantly change (E, p = ns).…”
  14. 154

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”
  15. 155

    Decreased Z-chromosome accessibility in the germline clusters. by Marwan Elkrewi (11879055)

    Published 2024
    “…The red line is at -1, and corresponds to a two fold decrease in the number of fragments.…”
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160

    Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

    Published 2025
    “…And the low-risk cohort exhibited increased immune infiltration and decreased tumor purity. Additionally, significant differences in tumor mutation profiles were observed, with the tumor mutation burden (TMB) being higher in the low-risk cohort, suggesting a potentially better response to immunotherapy. …”